The explosion of data has raised the stakes for marketers. Customers now expect campaigns tailored to their needs, and businesses can no longer afford to operate on guesswork. AI-powered marketing ...
Eli Lilly and Company today announced that the National Medical Products Administration (NMPA) in China has approved Kisunlatm (donanemab-azbt, 350 mg/20 mL every four weeks injection for IV infusion) ...
In addition to prioritizing patient comfort, the innovative blood collection system is designed to improve efficiency within laboratories. By reducing the time required for blood draws and minimizing ...